human | Q5 |
P496 | ORCID iD | 0000-0003-2967-1855 |
P106 | occupation | researcher | Q1650915 |
Q64094800 | -Induced Barrier Disruption Correlates With Elastase Activity and Marks Chronic Rhinosinusitis Severity |
Q91515096 | A Radiological Study Assessing the Prevalence of Frontal Recess Cells and the Most Common Frontal Sinus Drainage Pathways |
Q100754954 | A Scholarly Review of the Safety and Efficacy of Intranasal Corticosteroids Preparations in the Treatment of Chronic Rhinosinusitis |
Q48366123 | A case of traumatic infraorbital neuroma. |
Q84735147 | A randomized trial of mupirocin sinonasal rinses versus saline in surgically recalcitrant staphylococcal chronic rhinosinusitis |
Q38019434 | A systematic review of the endoscopic repair of cerebrospinal fluid leaks. |
Q84747317 | Adaptive immune responses in Staphylococcus aureus biofilm-associated chronic rhinosinusitis |
Q41206292 | Alloiococcus otitidis Forms Multispecies Biofilm with Haemophilus influenzae: Effects on Antibiotic Susceptibility and Growth in Adverse Conditions |
Q53144655 | Anatomic relationship of nasolacrimal duct and major lateral wall landmarks: cadaveric study with surgical implications. |
Q92891618 | Anatomical considerations in endoscopic lacrimal surgery |
Q50244354 | Association of intracellular Staphylococcus aureus with prognosis in chronic rhinosinusitis |
Q36814159 | Avascular necrosis after oral corticosteroids in otolaryngology: Case report and review of the literature. |
Q47169998 | Barosinusitis: Comprehensive review and proposed new classification system. |
Q50087963 | Biocompatibility and pharmacokinetics of fluticasone-eluting sinus implant in a rabbit model |
Q35488035 | Biofilm Quantification on Nasolacrimal Silastic Stents After Dacryocystorhinostomy |
Q53016552 | Bony nasolacrimal duct dehiscence in functional endoscopic sinus surgery: radiological study and discussion of surgical implications. |
Q37996938 | Changing trends in sinus and septal surgery, 2007 to 2009. |
Q45890667 | Characterization of B-cell subpopulations in patients with chronic rhinosinusitis. |
Q49356025 | Chronic Rhinosinusitis with Polyps Is Characterized by Increased Mucosal and Blood Th17 Effector Cytokine Producing Cells. |
Q57016514 | Comparative Viral Sampling in the Sinonasal Passages; Different Viruses at Different Sites |
Q38238869 | Complications associated with the pedicled nasoseptal flap for skull base reconstruction. |
Q41720698 | Cousins, siblings, or copies: the genomics of recurrent Staphylococcus aureus infections in chronic rhinosinusitis |
Q42062547 | Dacryocystorhinostomy ostium: parameters to evaluate and DCR ostium scoring |
Q64263152 | Deferiprone has anti-inflammatory properties and reduces fibroblast migration in vitro |
Q43586574 | Differences in skull base thickness in patients with spontaneous cerebrospinal fluid leaks. |
Q50873261 | Discordant frequencies of tissue-resident and circulating CD180-negative B cells in chronic rhinosinusitis. |
Q91480689 | Effect of commercial nasal steroid preparation on bacterial growth |
Q37590846 | Endoscopic Resection of Skull Base Teratoma in Klippel-Feil Syndrome through Use of Combined Ultrasonic and Bipolar Diathermy Platforms. |
Q43478180 | Endoscopic assessment of the dacryocystorhinostomy ostium after powered endoscopic surgery: behaviour beyond 4 weeks. |
Q38286232 | Endoscopic dacryocystorhinostomy and obstructive sleep apnoea: the effects and outcomes of continuous positive airway pressure therapy |
Q38934783 | Factors impacting cerebrospinal fluid leak rates in endoscopic sellar surgery. |
Q38655259 | Hemostasis in sinus surgery. |
Q85268351 | Impact of intraoperative hydrodebrider treatment on postoperative sinonasal inflammation |
Q93093830 | In vitro characteristics of an airway barrier-disrupting factor secreted by Staphylococcus aureus |
Q41918029 | In vitro safety evaluation of human nasal epithelial cell monolayers exposed to carrageenan sinus wash. |
Q88286524 | Increased IL-13 expression is independently associated with neo-osteogenesis in patients with chronic rhinosinusitis |
Q91331209 | Inducing a Mucosal Barrier-Sparing Inflammatory Response in Laboratory-Grown Primary Human Nasal Epithelial Cells |
Q84357532 | Innate immunity |
Q46518462 | Intraocular pressure changes in emergent surgical decompression of orbital compartment syndrome. |
Q34470755 | Is nasal packing necessary after septoplasty? A meta-analysis. |
Q38226528 | Long-term outcomes in primary powered endoscopic dacryocystorhinostomy. |
Q38245094 | Long-term outcomes in revision powered endoscopic dacryocystorhinostomy. |
Q38259922 | Long-term outcomes of endoscopic maxillary mega-antrostomy for refractory chronic maxillary sinusitis. |
Q38239473 | Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease. |
Q87421156 | Modification of the Lund-Kennedy endoscopic scoring system improves its reliability and correlation with patient-reported outcome measures |
Q89208929 | Mucosal zinc deficiency in chronic rhinosinusitis with nasal polyposis contributes to barrier disruption and decreases ZO-1 |
Q84553045 | Multi-institutional evaluation of a sinus surgery checklist |
Q47863311 | Nano-hemostats and a Pilot Study of Their Use in a Large Animal Model of Major Vessel Hemorrhage in Endoscopic Skull Base Surgery |
Q80982047 | Nasal mucosa expression of lactoferrin in patients with chronic rhinosinusitis |
Q38179285 | Nasal packing after septoplasty: cardiopulmonary impact. |
Q88001475 | Neurotoxicity Secondary to Bismuth Iodoform Paraffin Paste Packing in an Orbital Exenteration Cavity |
Q35983135 | Next Generation Sequencing and the Microbiome of Chronic Rhinosinusitis: A Primer for Clinicians and Review of Current Research, Its Limitations, and Future Directions. |
Q38268567 | Olfactory outcomes in chronic rhinosinusitis with nasal polyposis after medical treatments: a systematic review and meta-analysis. |
Q41683360 | Outcomes in primary powered endoscopic dacryocystorhinostomy: comparison between experienced versus less experienced surgeons. |
Q38780339 | Outcomes of modified endoscopic Lothrop in aspirin-exacerbated respiratory disease with nasal polyposis. |
Q92496993 | Outcomes of primary powered endoscopic dacryocystorhinostomy in syndromic congenital nasolacrimal duct obstruction |
Q39995606 | Outcomes of revision endoscopic modified Lothrop procedure. |
Q91834081 | Partial Adenoidectomy in Patients With Palatal Abnormalities |
Q91052605 | Phase 1 clinical study to assess the safety of a novel drug delivery system providing long-term topical steroid therapy for chronic rhinosinusitis |
Q48220754 | Platelet activation by crushed and uncrushed muscle: a flow cytometry analysis. |
Q38243847 | Powered endoscopic dacryocystorhinostomy: a decade of experience |
Q91572172 | Prelacrimal approach for nasolacrimal duct excision in the management of lacrimal system tumours |
Q86084052 | Prelacrimal approach to the maxillary sinus |
Q90581402 | Primary human nasal epithelial cells: a source of poly (I:C) LMW-induced IL-6 production |
Q33518063 | Radiofrequency coblation for treatment of advanced laryngotracheal recurrent respiratory papillomatosis. |
Q38721521 | Reduced Innate Immune Response to a Staphylococcus aureus Small Colony Variant Compared to Its Wild-Type Parent Strain |
Q86449112 | Reply to: In reference to: Medical therapy vs surgery for recurrent acute rhinosinusitis |
Q38694624 | Role of fungi in chronic rhinosinusitis through ITS sequencing |
Q54941831 | Safety and Efficacy of Topical Chitogel- Deferiprone-Gallium Protoporphyrin in Sheep Model. |
Q90922901 | Safety and efficacy of a bacteriophage cocktail in an in vivo model of Pseudomonas aeruginosa sinusitis |
Q88691479 | Sirtuin-1 Controls Poly (I:C)-Dependent Matrix Metalloproteinase 9 Activation in Primary Human Nasal Epithelial Cells |
Q47673432 | Staphylococcus Aureus V8 protease disrupts the integrity of the airway epithelial barrier and impairs IL-6 production in vitro. |
Q90584437 | Staphylococcus aureus small colony variants: Prevalence in chronic rhinosinusitis and induction by antibiotics |
Q53139426 | T regulatory and Th17 cells in chronic rhinosinusitis with polyps. |
Q91529759 | Teaching Residents Frontal Sinus Anatomy Using a Novel 3-Dimensional Conceptualization Planning Software-Based Module |
Q53801167 | Tertiary lymphoid organs in recalcitrant chronic rhinosinusitis. |
Q64980293 | Tertiary lymphoid organs: A novel target in patients with chronic rhinosinusitis. |
Q91152759 | The Association Between Disease Severity and Microbiome in Chronic Rhinosinusitis |
Q51031033 | The Dacryocystorhinostomy Ostium Granulomas: Classification, Indications for Treatment, Management Modalities and Outcomes. |
Q38435730 | The Frequency of Concomitant Adjunctive Nasal Procedures in Powered Endoscopic Dacryocystorhinostomy |
Q48728464 | The International Classification of the radiological Complexity (ICC) of frontal recess and frontal sinus |
Q48846180 | The International Frontal Sinus Anatomy Classification (IFAC) and Classification of the Extent of Endoscopic Frontal Sinus Surgery (EFSS). |
Q90297318 | The international sinonasal microbiome study: A multicentre, multinational characterization of sinonasal bacterial ecology |
Q40143732 | The persistence of intracellular Staphylococcus aureus in the sinuses: a longitudinal study. |
Q52562646 | Topical Colloidal Silver for the Treatment of Recalcitrant Chronic Rhinosinusitis. |
Q38297535 | Update on endoscopic endonasal resection of skull base meningiomas. |
Q90463517 | Vascular Anatomy of the Inferior Turbinate and Its Clinical Implications |
Q57814104 | from patients with chronic rhinosinusitis show minimal genetic association between polyp and non-polyp phenotypes |
Search more.